Filter
1739
Filtered Results: 1739
Text search:
European
Medicines
Agency
Featured
Recommendations
163
New Publications
355
Language
Document type
No document type
798
Studies & Reports
419
Guidelines
261
Manuals
110
Strategic & Response Plan
57
Fact sheets
39
Training Material
22
Situation Updates
21
Resource Platforms
5
Brochures
4
App
1
Infographics
1
Online Courses
1
Countries / Regions
Global
102
Western and Central Europe
94
Ukraine
55
Eastern Europe
35
Africa
29
Kenya
28
Ethiopia
25
Ghana
21
Sierra Leone
21
Nigeria
21
Zambia
21
Latin America and the Carribbean
19
Germany
19
Liberia
19
Myanmar / Burma
19
Nepal
18
Syria
18
India
18
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
South–East Asia Region
12
Philippines
11
Venezuela
11
West and Central Africa
11
Bangladesh
11
Uganda
11
Rwanda
10
Moldova
10
Namibia
10
Malawi
9
Zimbabwe
9
East and Southern Africa
9
Tajikistan
8
Senegal
8
Tanzania
8
Congo, Democratic Republic of
8
Thailand
7
Georgia
7
Indonesia
7
North Macedonia
6
Colombia
6
Burkina Faso
6
Jordan
6
Middle East and North Africa
6
Brazil
6
South Sudan
6
Cameroon
5
Albania
5
Mozambique
5
Cambodia
5
Asia
5
Paraguay
5
Yemen
5
Eswatini/ Swaziland
5
Benin
4
Haiti
4
Hungary
4
Sudan
4
Poland
4
Botswana
4
Somalia
4
Serbia
3
Lesotho
3
Turkey
3
China
3
Kazakhstan
3
Laos
3
Kyrgyzstan
3
Afghanistan
3
USA
3
Jamaica
3
Belarus
3
Lebanon
3
Vietnam
3
Romania
3
Pakistan
3
Chile
2
Iran
2
Estonia
2
Uzbekistan
2
Morocco
2
Bulgaria
2
Western Pacific Region
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Egypt
2
Central African Republic
2
Libya
2
Iraq
2
Madagascar
2
Mexico
1
El Salvador
1
Australia
1
Niger
1
Peru
1
Mongolia
1
Mauritania
1
Armenia
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Papua New Guinea
1
Slovakia
1
Greece
1
Mali
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
430
Clinical Guidelines
160
Key Resources
104
Public Health
92
Women & Child Health
80
Pharmacy & Technologies
30
Capacity Building
13
Toolboxes
COVID-19
165
Mental Health
164
HIV
138
TB
124
AMR
111
Planetary Health
83
Conflict
74
Rapid Response
73
Pharmacy
58
Refugee
52
Disability
49
Ebola & Marburg
48
Global Health Education
42
NTDs
33
NCDs
33
Health Financing Toolbox
32
Caregiver
31
Specific Hazards
18
Malaria
17
Zika
15
Natural Hazards
14
Polio
6
Cholera
3
Social Ethics
1
Una guía destinada al uso de los primeros respondedores
durante la fase inicial de un incidente en el transporte que
involucre mercancías peligrosas / materiales peligrosos
Diagnóstico exploratorio sobre el tráfico y/o trata de personas con fines de explotación sexual
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
16.7.2021
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This updated version, endorsed by the World Health Assembly in May 2021 through resolution WHA74.9, reflects lessons learned in the global malaria response over the last 5 years. While the milestones and targets remain the same, the approaches to tackling the disease, in some areas, have evolved to ...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
